RECOMBINANT HERPES SIMPLEX GB-GD VACCINE

摘要

Vaccines and therapeutic compositions useful for therapeutic treatment of disease caused by Herpes Simplex Virus (HSV) are provided. These vaccines and compositions employ recombinant HSV glycoproteins B and D. Treatment of an HSV infected individual with the vaccine or composition subsequent to infection with HSV alleviates recurrent disease due to HSV, even if the individual is treated during an acute phase of the disease when HSV induced lesions are present.